ES548789A0 - Un procedimiento para preparar derivados esteres del antibiotico l 17046. - Google Patents

Un procedimiento para preparar derivados esteres del antibiotico l 17046.

Info

Publication number
ES548789A0
ES548789A0 ES548789A ES548789A ES548789A0 ES 548789 A0 ES548789 A0 ES 548789A0 ES 548789 A ES548789 A ES 548789A ES 548789 A ES548789 A ES 548789A ES 548789 A0 ES548789 A0 ES 548789A0
Authority
ES
Spain
Prior art keywords
antibiotic
procedure
ester derivatives
preparing ester
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES548789A
Other languages
English (en)
Other versions
ES8704964A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of ES8704964A1 publication Critical patent/ES8704964A1/es
Publication of ES548789A0 publication Critical patent/ES548789A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
ES548789A 1984-11-13 1985-11-12 Un procedimiento para preparar derivados esteres del antibiotico l 17046. Expired ES8704964A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848428619A GB8428619D0 (en) 1984-11-13 1984-11-13 Derivatives of antibiotic l 17046

Publications (2)

Publication Number Publication Date
ES8704964A1 ES8704964A1 (es) 1987-04-16
ES548789A0 true ES548789A0 (es) 1987-04-16

Family

ID=10569641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548789A Expired ES8704964A1 (es) 1984-11-13 1985-11-12 Un procedimiento para preparar derivados esteres del antibiotico l 17046.

Country Status (13)

Country Link
US (1) US4661470A (es)
EP (1) EP0182157B1 (es)
JP (1) JPS61122300A (es)
KR (1) KR860004076A (es)
AT (1) ATE78261T1 (es)
CA (1) CA1250098A (es)
DE (1) DE3586344T2 (es)
DK (1) DK508885A (es)
ES (1) ES8704964A1 (es)
GB (1) GB8428619D0 (es)
HU (1) HU196228B (es)
IL (1) IL76996A0 (es)
ZA (1) ZA858449B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE873523L (en) * 1986-12-30 1988-06-30 Memorex Corp Glycosylated glycopeptides
US4882313A (en) * 1987-07-31 1989-11-21 Smithkline Beckman Corporation Carboxamide derivatives of glycopeptides
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
ATE242783T1 (de) 1998-12-23 2003-06-15 Theravance Inc Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
AR021964A1 (es) * 1998-12-23 2002-09-04 Theravance Inc Un compuesto glicopeptidico, composiciones farmaceuticas que los contienen y uso de dichos compuestos glicopeptidicos para la manufactura de un medicamento antibacteriano.
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US20050090433A1 (en) * 2002-11-18 2005-04-28 Vicuron Pharmaceuticals, Inc Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64486A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives

Also Published As

Publication number Publication date
US4661470A (en) 1987-04-28
HUT41053A (en) 1987-03-30
GB8428619D0 (en) 1984-12-19
DK508885D0 (da) 1985-11-05
HU196228B (en) 1988-10-28
DE3586344D1 (de) 1992-08-20
ES8704964A1 (es) 1987-04-16
IL76996A0 (en) 1986-04-29
DE3586344T2 (de) 1993-03-11
DK508885A (da) 1986-05-14
EP0182157A2 (en) 1986-05-28
ATE78261T1 (de) 1992-08-15
ZA858449B (en) 1986-08-27
EP0182157A3 (en) 1987-12-09
CA1250098A (en) 1989-02-14
EP0182157B1 (en) 1992-07-15
KR860004076A (ko) 1986-06-16
JPS61122300A (ja) 1986-06-10

Similar Documents

Publication Publication Date Title
GR861625B (en) Optically active pyridobenzoxazines derivatives and intermediate compounds thereof
ES459785A1 (es) Un procedimiento para la preparacion de nuevos esteres anti-bacterianos.
EP0177940A3 (en) Hydrazine derivatives and their use
JO1704B1 (en) New potent compounds
ES548789A0 (es) Un procedimiento para preparar derivados esteres del antibiotico l 17046.
AU2857492A (en) Improved fish production
ES458427A1 (es) Un procedimiento para la preparacion de 6-metoxi-alfa-car- boxi-penicilinas.
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.
DE3461806D1 (en) 2-desoxyoxanosine, a process for the preparation thereof and its use as a medicament
ES8107309A1 (es) Un procedimiento de produccion de derivados de 7 -metoxice- falosporina
SU731725A1 (ru) Производные дифенилилхинолина, обладающие противомикробной активностью
YU48092A (sh) Postupak za dobijanje dvostruko blokiranih 1 karba(1-delta)-3-cefem-4-karboksilnih kiselina
SU1455633A1 (ru) О,о-диизопропил-о-[1, 1-диметил-2-пропилтио-2-(о-о-диизопропилфосфорил)- имино]-этилфосфат, обладающий бактерицидной активностью
CA1271749C (en) HYDRAZIDE DERIVATIVES OF MONOCYCLIC .BETA.-LACTAMS WITH ANTIBIOTIC PROPERTIES
JPS5264492A (en) Preparation of novel antibiotics c18-205

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401